Please use this identifier to cite or link to this item: https://hdl.handle.net/1/1336
Title: Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study
Authors: Allen, Debra M ;Smith, David J ;Grulich, A.E.;Guy, R.;Amin, J.;Jin, F.;Selvey, C.;Holden, J.;Schmidt, H.A.;Zablotska, I.;Price, K.;Whittaker, B.;Chant, K.;Cooper, C.;McGill, S.;Telfer, B.;Yeung, B.;Levitt, G.;Ogilvie, E.E.;Dharan, N.J.;Hammoud, M.A.;Vaccher, S.;Watchirs-Smith, L.;McNulty, A.;Baker, D.;Bloch, M.;Bopage, R.I.;Brown, K.;Carr, A.;Carmody, C.J.;Collins, K.L.;Finlayson, R.;Foster, R.;Jackson, E.Y.;Lewis, D.A.;Lusk, J.;O'Connor, C.C.;Ryder, N.;Vlahakis, E.;Read, P.;Cooper, D.A.
Affliation: Central Coast Local Health District
Gosford Hospital
Issue Date: Nov-2018
Source: 5(11):e629-e637
Journal title: The Lancet HIV
Department: Sexual Health
Abstract: BACKGROUND: HIV pre-exposure prophylaxis (PrEP) is highly effective in men who have sex with men (MSM) at the individual level, but data on population-level impact are lacking. We examined whether rapid, targeted, and high-coverage roll-out of PrEP in an MSM epidemic would reduce HIV incidence in the cohort prescribed PrEP and state-wide in Australia's most populous state, New South Wales. METHODS: The Expanded PrEP Implementation in Communities-New South Wales (EPIC-NSW) study is an implementation cohort study of daily co-formulated tenofovir disoproxil fumarate and emtricitabine as HIV PrEP. We recruited high-risk gay men in a New South Wales-wide network of 21 clinics. We report protocol-specified co-primary outcomes at 12 months after recruitment of the first 3700 participants: within-cohort HIV incidence; and change in population HIV diagnoses in New South Wales between the 12-month periods before and after PrEP roll-out. The study is registered with ClinicalTrials.gov, number NCT02870790. FINDINGS: We recruited 3700 participants in the 8 months between March 1, 2016, and Oct 31, 2016. 3676 (99%) were men, 3534 (96%) identified as gay, and 149 (4%) as bisexual. Median age was 36 years (IQR 30-45 years). Overall, 3069 (83%) participants attended a visit at 12 months or later. Over 4100 person-years, two men became infected with HIV (incidence 0.048 per 100 person-years, 95% CI 0.012-0.195). Both had been non-adherent to PrEP. HIV diagnoses in MSM in New South Wales declined from 295 in the 12 months before PrEP roll-out to 221 in the 12 months after (relative risk reduction [RRR] 25.1%, 95% CI 10.5-37.4). There was a decline both in recent HIV infections (from 149 to 102, RRR 31.5%, 95% CI 11.3 to 47.3) and in other HIV diagnoses (from 146 to 119, RRR 18.5%, 95% CI -4.5 to 36.6). INTERPRETATION: PrEP implementation was associated with a rapid decline in HIV diagnoses in the state of New South Wales, which was greatest for recent infections. As part of a combination prevention approach, rapid, targeted, high-coverage PrEP implementation is effective to reduce new HIV infections at the population level. FUNDING: New South Wales Ministry of Health, Gilead Sciences.
URI: https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1336
DOI: 10.1016/s2352-3018(18)30215-7
Pubmed: https://pubmed.ncbi.nlm.nih.gov/30343026/
ISSN: 2352-3018
Publicaton type: Journal Article
Keywords: Public Health
Drug Therapy
Appears in Collections:Health Service Research

Show full item record

Page view(s)

22
checked on Feb 3, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.